These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8244177)

  • 1. High-dose-rate brachytherapy in primary stage I and II vaginal cancer.
    Nanavati PJ; Fanning J; Hilgers RD; Hallstrom J; Crawford D
    Gynecol Oncol; 1993 Oct; 51(1):67-71. PubMed ID: 8244177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
    Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Outcome with intracavitary high-dose-rate brachytherapy for primary vaginal cancer].
    Kong W; Sun J
    Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):94-6. PubMed ID: 11953073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM; Venkatraman E; Chi DS; Barakat RR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy alone for invasive vaginal cancer: outcome with intracavitary high dose rate brachytherapy versus conventional low dose rate brachytherapy.
    Kucera H; Mock U; Knocke TH; Kucera E; Pötter R
    Acta Obstet Gynecol Scand; 2001 Apr; 80(4):355-60. PubMed ID: 11264612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD; Rai B; Mallick I; Sharma SC
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated vaginal recurrences in endometrial carcinoma: treatment results using high-dose-rate intracavitary brachytherapy and external beam radiotherapy.
    Pai HH; Souhami L; Clark BG; Roman T
    Gynecol Oncol; 1997 Aug; 66(2):300-7. PubMed ID: 9264580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-year review of radiotherapy for vaginal cancer: an institutional experience.
    Lian J; Dundas G; Carlone M; Ghosh S; Pearcey R
    Gynecol Oncol; 2008 Nov; 111(2):298-306. PubMed ID: 18722657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical radiotherapy with high-dose-rate brachytherapy for uterine cervix cancer long-term results.
    Khor TH; Tuan JK; Hee SW; Tham IW
    Australas Radiol; 2007 Dec; 51(6):570-7. PubMed ID: 17958695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perineal template interstitial brachytherapy salvage for recurrent endometrial adenocarcinoma metastatic to the vagina.
    Nag S; Martínez-Monge R; Copeland LJ; Vacarello L; Lewandowski GS
    Gynecol Oncol; 1997 Jul; 66(1):16-9. PubMed ID: 9234914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy for the treatment of primary vaginal cancer.
    Samant R; Tam T; Dahrouge S; E C
    Radiother Oncol; 2005 Nov; 77(2):133-6. PubMed ID: 16260055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definitive radiation therapy for squamous cell carcinoma of the vagina.
    Frank SJ; Jhingran A; Levenback C; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):138-47. PubMed ID: 15850914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
    Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
    Lerouge D; Touboul E; Lefranc JP; Uzan S; Jannet D; Moureau-Zabotto L; Genestie C; Antoine M; Jamali M
    Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose-rate intracavitary brachytherapy for cervical carcinomas with lower vaginal infiltration.
    Kazumoto T; Kato S; Tabushi K; Kutsutani-Nakamura Y; Mizuno H; Takahashi M; Shiromizu K; Saito Y
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1157-66. PubMed ID: 17459604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose-rate brachytherapy as the primary treatment of medically inoperable stage I-II endometrial carcinoma.
    Nguyen C; Souhami L; Roman TN; Clark BG
    Gynecol Oncol; 1995 Dec; 59(3):370-5. PubMed ID: 8522257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy.
    Chadha M; Nanavati PJ; Liu P; Fanning J; Jacobs A
    Gynecol Oncol; 1999 Oct; 75(1):103-7. PubMed ID: 10502434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and toxicity of MDR versus HDR brachytherapy for primary vaginal cancer.
    Rutkowski T; Białas B; Rembielak A; Fijałkowski M; Nowakowski K
    Neoplasma; 2002; 49(3):197-200. PubMed ID: 12098007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results.
    Dimopoulos JC; Schmid MP; Fidarova E; Berger D; Kirisits C; Pötter R
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1880-8. PubMed ID: 21868174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.